<?xml version="1.0" encoding="UTF-8"?>
<p id="p0100">The MAPKs (mitogen activated protein kinases) mediate several cellular activities involved in the cancer progression such as evading apoptosis, inducing proliferation and immune escape (
 <xref rid="bib11" ref-type="bibr">Cargnello and Roux, 2011</xref>; 
 <xref rid="bib64" ref-type="bibr">Peluso et al., 2019</xref>). MAPK family includes following members: c-Jun N terminal kinase (JNK), ERK (extracellular signal-regulated kinase) and the p38 MAPK (
 <xref rid="bib76" ref-type="bibr">Soares-Silva et al., 2016</xref>). Phosphatidylinositol 3-kinase (PI3K)/Akt is one of the most important intracellular pathway that perform several important roles in proliferation, cell growth and survival which makes it an attractive target for cancer therapy (
 <xref rid="bib94" ref-type="bibr">Yang et al., 2019</xref>).
</p>
